Contribution of the contrast enhanced ultrasound in the differential diagnosis of the focal lesions;Přĺnos kontrastního ultrazvukového vyšetřenív diferenciální diagnostice ložiskových procesů jater

Ceska Radiologie

Volumn 64, Issue 1, 2010, Pages 11-19

  Bohatá, Šárka ^a   Pavlík, Tomáš ^b   Chlumská, Danuše ^a   Válek, Vlastimil ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Diagnosis; Differential; Liver; Microbubbles; Ultrasonography

Indexed keywords

ALGORITHM; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HISTOLOGY; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

EID: 77952503326     PISSN: 12107883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. st ed. Pisa, Italy: Springer 2006; 252 s.
2. Averkiou M, Powers J. Ultrasound contrast media in the characterisation of soft tissue lesions: ongoing research. Medica-Mundi 2007; 51(2,3): 11.
3. st ed. Milano, Italy: Springer 2003.
4. Schneider G, Grazioli L, Saini S. MRI of the liver, 2nd edition. Milano, Italy: Springer 2006; 412 s.
5. Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions - diagnostic accuracy in clinical practice[1] (DEGUM multicenter trial), Ultraschall in Med 2008; 29:499-505, DOI: 10.1055/s-2008-1027806
6. Averkiou MA, Roundhill DN, Powers JE. New imaging technique based on the nonlinear properties of tissues. Proceedings of hte IEEE ultrasonic Symposium 1997; 2:1561-1566.
7. Burns PN, Wilson SR, Simpson WH. Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35(1): 58-71.
8. Catalano O, Nunziata A, Lobianco R, Siani A. Real-time harmonic contrast material specific US of focal liver lesions. Radiographics 2005; 25: 333-349. (Pubitemid 40547049)
9. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent enhancement patterns with pulse - inversion harmonic US. Radiology 2000; 216: 411-417.
10. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrastspecific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 2004; 232: 420-430. (Pubitemid 38971282)
11. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. RadioGraphics 2004; 24: 921-935. (Pubitemid 38943326)
12. Stieger S, Caskey Ch, Adamson R, et al. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology 2007; 243: 112-121.
13. Oliver JH, Baron RL. Helical biphasic contrast-enhanced CT of the Liver: techniwue, indications, interpretation and pitfalls. Radiology 1996, 201; 1-14.
14. Válek V, Kala Z, Kiss I, et al. Maligní ložiskové procesy jater. Diagnostika a léčba včetně minimálně invazivních metod, 1. vydání. Praha: Grada Publishing 2006; 416 s.
15. Weis J, Bořuta P. Úvod do magnetické rezonancie. Bratislava: Datex 1998.
16. Reimer P, Parizel PM, Stichnoth FA. Clinical MR imaging. A practical approach, 2nd edition. Heidelberg, Germany: Springer 2003; 1-65, 271-273.
17. Leen E, Ceccotti P, Kalogeropoulou Ch, et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography; AJR 2006; 186: 1551-1559.
18. Soye JA, Mullan CP, Porter S, et al. The use of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Ulster Med J 2007; 76(1): 22-25. (Pubitemid 46157345)
19. Isozaki T, Nemata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003; 229: 798-805.
20. Dietrich CF, Kratzer W, Strobe D, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12(11): 1699-1705.
21. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase inversion sonography during the liver specific late phase of contrast enhancement: improved detection of liver metastases. AJR 2001; 176: 1191-1198.
22. Mechl M, Válek V, Bruel P, et al. Characterisation of the solid liver lesions by CEUS-multicenter international study. Czech Radiology 2007; 60; 5: 387.
23. Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue®-enhanced sonography: International multicenter-study incomparison to CT and MRI. World J Gastroenterol 2009; 15(30): 3748-3756.
24. Albrecht T, Blomley MKJ, Burns PN, et al. Improved detection of hepatic metastases with pulse inversion ultrasonography during the liver specific phase of SHU 508A (Levovist) - a multi-centre study. Radiology 2002; 227: 361-370.
25. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small (less than or equal 15 mm) hepatic lesions detected by CT. AJR 1992; 158: 535-539.
26. Leifer D, Middleton W. Teefey S, et al. Follow-up of patiens at low risk for hepatic malignancy with a characteristic haemangioma at US. Radiology 2000; 214: 167-172.
27. Schwarz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importace of small hepatic lesions found at CT in patients with cancer. Radiology 1999; 210: 71-74.
28. Caturelli E, Pompili M, Bartolucci F, et al. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patiens. Radiology 2001; 220: 337-342.
29. Shimizu A, Ito K, Koike S, et al. Cirrhosis or chronic hepatitis: evaluation of small (2 cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003; 226: 550-555. (Pubitemid 36313448)
30. Kolombo M, De Frachis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patiens with cirrhosis; Lancet 1991; 325: 675-680.
31. Zoli M, Magolotti D, Bianchi G, et al. Efficacy of surveillance program for early detection of hepatocellular carcinoma; Cancer 1996; 78: 977-985.
32. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcino- ma in a North American urban population. Hematology 1995; 22: 432-438.
33. Collier J, Herman M. Screening for hepatocellular carcinoma. Hematology 1998; 27: 273-278.
34. Bruix J, Sherman M, Llovet JM, et al. EASL. Panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35(3): 421-430.
35. Takamori R, Wong L, Dang C. Needle-tract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72.